Wells Fargo’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-40,480
| Closed | -$5.67M | – | 6323 |
|
2018
Q4 | $5.67M | Buy |
40,480
+19,959
| +97% | +$2.8M | ﹤0.01% | 2302 |
|
2018
Q3 | $3.51M | Buy |
20,521
+5,916
| +41% | +$1.01M | ﹤0.01% | 2921 |
|
2018
Q2 | $2.53M | Sell |
14,605
-1,533
| -9% | -$266K | ﹤0.01% | 3231 |
|
2018
Q1 | $1.86M | Buy |
16,138
+428
| +3% | +$49.4K | ﹤0.01% | 3402 |
|
2017
Q4 | $1.32M | Sell |
15,710
-2,318
| -13% | -$195K | ﹤0.01% | 3660 |
|
2017
Q3 | $1.66M | Buy |
18,028
+1,933
| +12% | +$178K | ﹤0.01% | 3403 |
|
2017
Q2 | $1.29M | Buy |
16,095
+592
| +4% | +$47.5K | ﹤0.01% | 3475 |
|
2017
Q1 | $653K | Buy |
15,503
+3,875
| +33% | +$163K | ﹤0.01% | 3982 |
|
2016
Q4 | $373K | Buy |
11,628
+5,044
| +77% | +$162K | ﹤0.01% | 4261 |
|
2016
Q3 | $172K | Buy |
6,584
+1,874
| +40% | +$49K | ﹤0.01% | 4392 |
|
2016
Q2 | $109K | Sell |
4,710
-174
| -4% | -$4.03K | ﹤0.01% | 4603 |
|
2016
Q1 | $133K | Buy |
4,884
+143
| +3% | +$3.89K | ﹤0.01% | 4492 |
|
2015
Q4 | $134K | Buy |
4,741
+3,709
| +359% | +$105K | ﹤0.01% | 4548 |
|
2015
Q3 | $18K | Sell |
1,032
-358
| -26% | -$6.24K | ﹤0.01% | 5328 |
|
2015
Q2 | $25K | Buy |
1,390
+218
| +19% | +$3.92K | ﹤0.01% | 5321 |
|
2015
Q1 | $14K | Buy |
1,172
+1,004
| +598% | +$12K | ﹤0.01% | 5306 |
|
2014
Q4 | $2K | Buy |
+168
| New | +$2K | ﹤0.01% | 5777 |
|